Modelling uveal melanoma

被引:10
|
作者
Foss, AJE [1 ]
Cree, IA
Dolin, PJ
Hungerford, JL
机构
[1] Univ Nottingham Hosp, Queens Med Ctr, Directorate Ophthalmol, Nottingham NG7 2UH, England
[2] Univ London, Inst Ophthalmol, Dept Pathol, London EC1V 9EL, England
[3] WHO, TB Program, CH-1211 Geneva, Switzerland
[4] Moorfields Eye Hosp, Oncol Clin, London EC1V 2PD, England
关键词
D O I
10.1136/bjo.83.5.588
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background/aim-There has been no consistent pattern reported on how mortality for uveal melanoma varies with age. This information can be useful to model the complexity of the disease. The authors have examined ocular cancer trends, as an indirect measure for uveal melanoma mortality, to see how rates vary with age and to compare the results with their other studies on predicting metastatic disease. Methods-Age specific mortality was examined for England and Wales, the USA, and Canada. A log-log model was fitted to the data. The slopes of the log-log plots were used as measure of disease complexity and compared with the results of previous work on predicting metastatic disease. Results-The log-log model provided a good fit for the US and Canadian data, but the observed rates deviated for England and Wales among people over the age of 65 years. The log-log model for mortality data suggests that the underlying process depends upon four rate limiting steps, while a similar model for the incidence data suggests between three and four rate limiting steps. Further analysis of previous data on predicting metastatic disease on the basis of tumour size and blood vessel density would indicate a single rate limiting step between developing the primary tumour and developing metastatic disease. Conclusions-There is significant underreporting or underdiagnosis of ocular melanoma for England and Wales in those over the age of 65 years. In those under the age of 65, a model is presented for ocular melanoma oncogenesis requiring three rate limiting steps to develop the primary tumour and a fourth rate limiting step to develop metastatic disease. The three steps in the generation of the primary tumour involve two key processes-namely, growth and angiogenesis within the primary tumour. The step from development of the primary to development of metastatic disease is likely to involve a single rate limiting process.
引用
收藏
页码:588 / 594
页数:7
相关论文
共 50 条
  • [21] CYTOGENETICS OF UVEAL MELANOMA
    SISLEY, K
    COTTAM, D
    RENNIE, IG
    POTTER, AM
    POTTER, CW
    REES, RC
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 1243 - 1243
  • [22] Metastatic Uveal Melanoma
    Sacks, Chana A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (19): : 1853 - 1853
  • [23] UVEAL MELANOMA MANAGEMENT
    CHAR, DH
    GRAGOUDAS, ES
    PHILLIPS, TL
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1989, 73 (06) : 476 - 477
  • [24] PROGNOSIS IN UVEAL MELANOMA
    BENJAMIN, B
    CUMINGS, JN
    GOLDSMITH, AJB
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1948, 32 (10) : 737 - 747
  • [25] Tebentafusp for uveal melanoma
    Killock, David
    NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (12) : 747 - 747
  • [26] Proteomics in uveal melanoma
    Ramasamy, Pathma
    Murphy, Conor C.
    Clynes, Martin
    Horgan, Noel
    Moriarty, Paul
    Tiernan, Damien
    Beatty, Stephen
    Kennedy, Susan
    Meleady, Paula
    EXPERIMENTAL EYE RESEARCH, 2014, 118 : 1 - 12
  • [27] Uveal (intraocular) melanoma
    McLean, W
    Gamel, JW
    CANCER JOURNAL - FRANCE, 1996, 9 (01): : 20 - 25
  • [28] Proteomics in uveal melanoma
    Missotten, GS
    Beijnen, JH
    Keunen, JEE
    Bonfrer, JMG
    MELANOMA RESEARCH, 2003, 13 (06) : 627 - 629
  • [29] The biology of uveal melanoma
    Adriana Amaro
    Rosaria Gangemi
    Francesca Piaggio
    Giovanna Angelini
    Gaia Barisione
    Silvano Ferrini
    Ulrich Pfeffer
    Cancer and Metastasis Reviews, 2017, 36 : 109 - 140
  • [30] Overview of uveal melanoma
    Martorano, Lisa M.
    Winkelmann, Richard R.
    Cebulla, Colleen M.
    Abdel-Rahman, Mohamed H.
    Campbell, Shannon M.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2014, 53 (06) : 657 - 663